Celiac disease does not influence markers of ovarian reserve in adolescent girls


Comba C., Comba A., Yılmaz H., ERDOĞAN S., DEMİR Ö.

Archives of Gynecology and Obstetrics, cilt.302, sa.5, ss.1263-1269, 2020 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 302 Sayı: 5
  • Basım Tarihi: 2020
  • Doi Numarası: 10.1007/s00404-020-05666-4
  • Dergi Adı: Archives of Gynecology and Obstetrics
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CINAHL, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.1263-1269
  • Anahtar Kelimeler: Celiac disease, Anti-mullerian hormone, Adolescent, Follicle stimulating hormone, Antral follicle counts
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

Purpose: The aim of the study was to determine whether celiac disease affects ovarian reserve assessed by antral follicle counting, ovarian volume, and anti-müllerian hormone in adolescent patients. Methods: This case–control multicenter trial was performed from January 1, 2017 to May 31, 2018 and included 45 girls. On days 2–5 of the menstrual cycle, measurements of serum follicle stimulating hormone, luteinizing hormone, estradiol, prolactin, and anti-müllerian hormone were performed. Antral follicle counts and ovarian volumes were determined on the same day. Results: Evaluation was made of 21 (47.7%) celiac patients with a mean age of 15.8 ± 1.3 years, and 24 (52.3%) healthy control subjects with a mean age of 16.2 ± 1.2. There was no difference between the groups in respect of right and left ovarian volumes (p = 0.790 and p = 0.670, respectively). Serum levels of anti-müllerian hormone of the celiac patients and controls were found comparable [(3.7 ± 2.9 (0.5–12) and 3.6 ± 1.8 (1.2–8.1)] ng/mL, respectively, p = 0.915). Conclusions: Celiac disease may not affect the ovarian reserve determined with established ovarian reserve markers including antral follicle counting, ovarian volume, and anti-müllerian hormone in adolescent patients. Trial registration: ClinicalTrials.gov identifier (NCT number): NCT04024449 https://clinicaltrials.gov/ct2/show/NCT04024449.